These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 31819367)

  • 1. Assessment Of Spanlastic Vesicles Of Zolmitriptan For Treating Migraine In Rats.
    El-Nabarawy NA; Teaima MH; Helal DA
    Drug Des Devel Ther; 2019; 13():3929-3937. PubMed ID: 31819367
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Population Pharmacokinetic Analysis of Zolmitriptan and Its Metabolite in Adults and Adolescents to Support Dose Selection in Children With Migraine.
    Zhou W; Li J; Birmingham B; Xu H; Lillieborg S; Zhou D; Al-Huniti N
    J Clin Pharmacol; 2017 Oct; 57(10):1258-1267. PubMed ID: 28581633
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of submicron emulsion as vehicles for rapid-onset intranasal delivery and improvement in brain targeting of zolmitriptan.
    Yu C; Gu P; Zhang W; Cai C; He H; Tang X
    Drug Deliv; 2011 Nov; 18(8):578-85. PubMed ID: 21838542
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intranasal zolmitriptan for the treatment of acute migraine.
    Tepper SJ; Chen S; Reidenbach F; Rapoport AM
    Headache; 2013 Sep; 53 Suppl 2():62-71. PubMed ID: 24024604
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetic study and brain tissue analysis of Zolmitriptan loaded chitosan nanoparticles in rats by LC-MS method.
    Khezri FANZ; Lakshmi CSR; Bukka R; Nidhi M; Nargund SL
    Int J Biol Macromol; 2020 Jan; 142():52-62. PubMed ID: 31593739
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of Brain Targeting Potential of Zolmitriptan Mucoadhesive Nanoparticles for Intranasal Drug Delivery.
    Jha S; Mishra D
    Pharm Nanotechnol; 2022; 10(2):113-124. PubMed ID: 35240970
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of ADAM Zolmitriptan for the Acute Treatment of Difficult-to-Treat Migraine Headaches.
    Tepper SJ; Dodick DW; Schmidt PC; Kellerman DJ
    Headache; 2019 Apr; 59(4):509-517. PubMed ID: 30698272
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intranasal zolmitriptan.
    Gawel M; Worthington I
    Expert Opin Pharmacother; 2005 Jun; 6(6):1019-24. PubMed ID: 15952929
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A coupled bimodal SPECT-CT imaging and brain kinetics studies of zolmitriptan-encapsulated nanostructured polymeric carriers.
    Mandlik SK; Ranpise NS; Mohanty BS; Chaudhari PR
    Drug Deliv Transl Res; 2018 Jun; 8(3):797-805. PubMed ID: 29380155
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Randomized, double-blind, placebo-controlled, parallel-group, multi-center study of the safety and efficacy of ADAM zolmitriptan for the acute treatment of migraine.
    Spierings EL; Brandes JL; Kudrow DB; Weintraub J; Schmidt PC; Kellerman DJ; Tepper SJ
    Cephalalgia; 2018 Feb; 38(2):215-224. PubMed ID: 29022755
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myalgia and cramps associated with zolmitriptan.
    Alonso-Navarro H; Jiménez-Jiménez FJ
    Clin Neuropharmacol; 2005; 28(5):241-2. PubMed ID: 16239765
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Zolmitriptan intranasal: a review of the pharmacokinetics and clinical efficacy.
    Goadsby PJ; Yates R
    Headache; 2006 Jan; 46(1):138-49. PubMed ID: 16412161
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trans-nasal zolmitriptan novasomes: in-vitro preparation, optimization and in-vivo evaluation of brain targeting efficiency.
    Abd-Elal RM; Shamma RN; Rashed HM; Bendas ER
    Drug Deliv; 2016 Nov; 23(9):3374-3386. PubMed ID: 27128792
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and tolerability of zolmitriptan oral tablet in the acute treatment of menstrual migraine.
    Tuchman M; Hee A; Emeribe U; Silberstein S
    CNS Drugs; 2006; 20(12):1019-26. PubMed ID: 17140280
    [TBL] [Abstract][Full Text] [Related]  

  • 15. One should avoid retro-orbital pharmacokinetic sample collections for intranasal dosing in rats: Illustration of spurious pharmacokinetics generated for anti-migraine drugs zolmitriptan and eletriptan.
    Patel H; Patel P; Modi N; Shah S; Ghoghari A; Variya B; Laddha R; Baradia D; Dobaria N; Mehta P; Srinivas NR
    Eur J Pharm Sci; 2017 Aug; 106():87-93. PubMed ID: 28549679
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fast relief from migraine attacks using fast-disintegrating sublingual zolmitriptan tablets.
    Mahmoud AA; Salah S
    Drug Dev Ind Pharm; 2012 Jun; 38(6):762-9. PubMed ID: 22023340
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Duel-acting subcutaneous microemulsion formulation for improved migraine treatment with zolmitriptan and diclofenac: formulation and in vitro-in vivo characterization.
    Dubey R; Martini LG; Christie M
    AAPS J; 2014 Mar; 16(2):214-20. PubMed ID: 24363199
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Symptomatic treatment of migraine with zolmitriptan: experience with 82 patients].
    Pascual J; Navarro A; Caminero AB; Jurado C; Díaz-Insa S; Huerta M
    Neurologia; 2006 May; 21(4):188-91. PubMed ID: 16832773
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Zolmitriptan oral tablet in migraine treatment: high placebo responses in adolescents.
    Rothner AD; Wasiewski W; Winner P; Lewis D; Stankowski J
    Headache; 2006 Jan; 46(1):101-9. PubMed ID: 16412157
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In-vitro and in-vivo respiratory deposition of a developed metered dose inhaler formulation of an anti-migraine drug.
    Abdou EM; Kandil SM; Morsi A; Sleem MW
    Drug Deliv; 2019 Dec; 26(1):689-699. PubMed ID: 31274014
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.